MIR600HG and gastric cancer: For example, MIR600HG is a potential therapeutic target and molecular biomarker in PAAD (Song et al., 2018); LINC00941is thought to be associated with tumor cell proliferation and metastasis in gastric cancer (Liu et al., 2019), which affects genes and proteoglycans in cancer, the Hippo signaling pathway, cancer pathways, the cell cycle and leukocyte transendothelial migration (Luo et al., 2018); Hu et al. Showed that CASC8 could reduce the glycolysis of bladder cancer cells and inhibit the growth of bladder cancer cells (Hu et al., 2017).